Afanat 40 Mg Afatinib 40 Mg Tablet

Name: Afanat 40 Mg Afatinib 40 Mg Tablet
Brand: Welox Pharma Private Limited
Price: 6500 INR
Availability: InStock

Price 6500 INR/ Box

Get a Price/Quote

MOQ : 100 Boxes

Afanat 40 Mg Afatinib 40 Mg Tablet Specification

Origin of Medicine
India

Dosage Form
Tablet

Pacakaging (Quantity Per Box)
28 Tablets

Life Span
Check expiry on packaging

Salt Composition
Afatinib 40 mg

Indication
Non-small cell lung cancer (NSCLC)

Packaging Type
Box

Drug Type
Prescription

Ingredients
Afatinib

Physical Form
Tablet

Function
Antineoplastic, EGFR inhibitor

Recommended For
Adults with non-small cell lung cancer

Dosage
40 mg once daily or as prescribed

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
28 Tablets

Storage Instructions
Store below 30C, protected from moisture

Market Segment
Oncology

Strength
40 mg

Color
Uncoated, standard tablet

Pack Label
Afatinib Tablets 40mg

Route of Administration
Oral

Brand Name
Afanat-40

Afanat 40 Mg Afatinib 40 Mg Tablet Trade Information

Minimum Order Quantity
100 Boxes

Supply Ability
5000 Boxes Per Month

Delivery Time
7 Days

Afanat 40 Mg Afatinib 40 Mg Tablet About

Afanat-40 Mg Tablet offers an outstanding approach for adults diagnosed with non-small cell lung cancer (NSCLC). This praiseworthy oral medication uses the latest EGFR inhibitor, Afatinib, providing dominant antineoplastic effects in oncology care. The ephemeral benefit of targeted therapy enables patients to take advantage of innovative treatment while maintaining daily routines. Each uncoated tablet, crafted in India, contains 40 mg of Afatinib and comes in practical boxes of 28 tablets. Store below 30C, away from moisture, and always refer to prescribing information for dosage details.

Outstanding Features and Application of Afanat-40 Tablets

Afanat-40 Mg Tablets, engineered with precision, are suitable for standard administration in clinics and hospitals focusing on oncology. As an uncoated, easy-to-administer oral tablet, its dominant strength is the selective targeting of EGFR pathways, delivering praiseworthy therapeutic results. The primary competitive advantages include reliable dosage consistency, a robust supply originating from India, and a format adaptable for global institutions treating non-small cell lung cancer.

Sample Policy, Export Markets, and Supply Ability for Afanat-40

For Afanat-40 Mg Tablets, prompt sample policy allows for quick quotations on request. Efficient transportation methods ensure samples and orders are delivered securely. Main export markets include Asia, Africa, and the Middle East, supporting reliable international distribution. Suppliers maintain a constant supply ability, fulfilling regular and bulk orders as per demand, ensuring quality assurance at every delivery, and ensuring the product reaches healthcare providers efficiently.

FAQ's of Afanat 40 Mg Afatinib 40 Mg Tablet:

Q: How should Afanat-40 Mg Afatinib Tablets be taken for optimal benefit?

A: Afanat-40 should be administered orally, 40 mg once daily, or as directed by your physician. It is crucial to follow your doctor's instructions closely for best results.

Q: What is the primary usage of Afanat-40 Mg Tablets?

A: These tablets are primarily prescribed for adults with non-small cell lung cancer (NSCLC) and function as a targeted EGFR inhibitor.

Q: Where should Afanat-40 Mg Tablets be stored to maintain efficacy?

A: Store Afanat-40 tablets below 30C in a moisture-protected environment. Always check the expiry date on the packaging before use.

Q: When is Afanat-40 Mg recommended?

A: Afanat-40 Mg is recommended when a patient has been diagnosed with EGFR mutation-positive non-small cell lung cancer, and a healthcare professional prescribes it as part of their cancer treatment regimen.

Q: What are the main benefits of taking Afanat-40 Mg Afatinib Tablets?

A: The main benefits include targeted therapy for NSCLC, potentially reducing tumor progression, and the convenience of a once-daily oral dosage for patients.

Tell us about your requirement